Cell-Type-Specific Adhesiveness and Proliferation Propensity on Laminin Isoforms Enable Purification of iPSC-Derived Corneal Epithelium.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
14 04 2020
Historique:
received: 07 05 2019
revised: 20 02 2020
accepted: 24 02 2020
pubmed: 21 3 2020
medline: 7 2 2021
entrez: 21 3 2020
Statut: ppublish

Résumé

A treatment for intractable diseases is expected to be the replacement of damaged tissues with products from human induced pluripotent stem cells (hiPSCs). Target cell purification is a critical step for realizing hiPSC-based therapy. Here, we found that hiPSC-derived ocular cell types exhibited unique adhesion specificities and growth characteristics on distinct E8 fragments of laminin isoforms (LNE8s): hiPSC-derived corneal epithelial cells (iCECs) and other non-CECs rapidly adhered preferentially to LN332/411/511E8 and LN211E8, respectively, through differential expression of laminin-binding integrins. Furthermore, LN332E8 promoted epithelial cell proliferation but not that of the other eye-related cells, leading to non-CEC elimination by cell competition. Combining these features with magnetic sorting, highly pure iCEC sheets were fabricated. Thus, we established a simple method for isolating iCECs from various hiPSC-derived cells without using fluorescence-activated cell sorting. This study will facilitate efficient manufacture of iCEC sheets for corneal disease treatment and provide insights into target cell-specific scaffold selection.

Identifiants

pubmed: 32197114
pii: S2213-6711(20)30064-3
doi: 10.1016/j.stemcr.2020.02.008
pmc: PMC7160305
pii:
doi:

Substances chimiques

Integrins 0
Laminin 0
Protein Isoforms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-676

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Dev Dyn. 2000 Jun;218(2):213-34
pubmed: 10842354
Cell. 1993 May 21;73(4):713-24
pubmed: 8500165
Cell Tissue Bank. 2017 Dec;18(4):443-460
pubmed: 28821996
Nat Biotechnol. 2001 Oct;19(10):971-4
pubmed: 11581665
Wound Repair Regen. 2001 Nov-Dec;9(6):483-94
pubmed: 11896990
Curr Opin Cell Biol. 2017 Oct;48:106-112
pubmed: 28719866
Stem Cells. 2008 Jan;26(1):235-43
pubmed: 17932419
Nature. 2012 Apr 15;484(7395):546-9
pubmed: 22504183
Nat Biotechnol. 2010 Jun;28(6):611-5
pubmed: 20512123
Cell Rep. 2018 Nov 6;25(6):1668-1679.e5
pubmed: 30404017
Invest Ophthalmol Vis Sci. 1981 Jul;21(1 Pt 1):135-42
pubmed: 7251297
Nature. 2016 Mar 17;531(7594):376-80
pubmed: 26958835
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Curr Opin Cell Biol. 2018 Apr;51:15-21
pubmed: 29153702
Cell Mol Life Sci. 2004 Nov;61(21):2774-81
pubmed: 15549181
Cytometry. 1990;11(2):231-8
pubmed: 1690625
Matrix Biol. 2006 Apr;25(3):189-97
pubmed: 16413178
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Nat Commun. 2012;3:1236
pubmed: 23212365
Biochem Biophys Res Commun. 2008 Mar 7;367(2):256-63
pubmed: 18155160
Nat Protoc. 2017 Apr;12(4):683-696
pubmed: 28253236
Stem Cells Transl Med. 2013 Oct;2(10):758-65
pubmed: 23981725
Nat Commun. 2014 Jul 31;5:4428
pubmed: 25079702
Nature. 2019 Apr;568(7752):344-350
pubmed: 30944469
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12849-54
pubmed: 18757743
Sci Rep. 2018 Nov 8;8(1):16550
pubmed: 30410112
Exp Dermatol. 2001 Feb;10(1):45-54
pubmed: 11168579
Nature. 2012 Apr 15;484(7395):542-5
pubmed: 22504180
Curr Top Membr. 2015;76:197-229
pubmed: 26610915
Exp Eye Res. 2005 Apr;80(4):581-90
pubmed: 15781286
Dev Cell. 2013 Jul 15;26(1):19-30
pubmed: 23867226
Matrix Biol. 2005 Aug;24(5):326-32
pubmed: 15979864
Oral Dis. 2008 Jul;14(5):413-8
pubmed: 18466216
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Stem Cell Res. 2017 Dec;25:256-265
pubmed: 29179035

Auteurs

Shun Shibata (S)

Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Research and Development Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Osaka 544-8666, Japan.

Ryuhei Hayashi (R)

Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan. Electronic address: ryuhei.hayashi@ophthal.med.osaka-u.ac.jp.

Yuji Kudo (Y)

Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Research and Development Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Osaka 544-8666, Japan.

Toru Okubo (T)

Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Research and Development Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Osaka 544-8666, Japan.

Tsutomu Imaizumi (T)

Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Research and Development Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Osaka 544-8666, Japan.

Tomohiko Katayama (T)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Yuki Ishikawa (Y)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Yuki Kobayashi (Y)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan.

Junko Toga (J)

Division of Matrixome Research and Application, Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.

Yukimasa Taniguchi (Y)

Division of Matrixome Research and Application, Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.

Yoichi Honma (Y)

Department of Stem Cells and Applied Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Research and Development Division, ROHTO Pharmaceutical Co., Ltd., Osaka, Osaka 544-8666, Japan.

Kiyotoshi Sekiguchi (K)

Division of Matrixome Research and Application, Institute for Protein Research, Osaka University, Suita, Osaka 565-0871, Japan.

Kohji Nishida (K)

Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Osaka 565-0871, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH